Mark Lawler: How the island of Ireland is punching above its weight in cancer research
Mark Lawler, Chair in Translational Cancer Genomics at Queen’s University Belfast, Centre for Cancer Research and Cell Biology, shared a post on X:
“Great coverage in IrishCentral on how the island of Ireland is punching above its weight in cancer research, acting as a bridge for transatlantic cooperation between Europe and the US.”
Dr. Mark Lawler is the Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, Centre for Cancer Research and Cell Biology. He is also a Visiting Professor in Human Genetics and Molecular Medicine at the University of Chieti Pescara, Italy.
His specialties include genetics, molecular medicine, cancer biology, drug discovery, graduate education, bioethics, science policy, art therapy, and public perception of science.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023